Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
AURA is expected to report earnings to fall 15.09% to -46 cents per share on August 11
Q2'25
Est.
$-0.47
Q1'25
Missed
by $0.07
Q4'24
Missed
by $0.08
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.04
The last earnings report on May 15 showed earnings per share of -55 cents, missing the estimate of -47 cents. With 11.07K shares outstanding, the current market capitalization sits at 421.63M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AURA showed earnings on May 15, 2025. You can read more about the earnings report here.